-
-
-
-
-
-
-
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
-
-
-
-
-
-
-
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Tops Q1 EPS by 22c
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) PT Raised to $12 at Benchmark
-
-
-
-
-
-
-
Emergent BioSolutions to Release Second Quarter 2024 Financial Results & Conduct Conference Call on August 6, 2024
-
-
-
-
-
-
-
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
-
-
-
-
-
-
-
Emergent BioSolutions (EBS) Receives NYSE Notice Regarding Delayed Form 10-Q Filing
-
1,207,776 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

